![Caroline Thielen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Caroline Thielen currently works at Exevir Bio BV, as Director, Dendrogenix SA, as Director, and Promethera Therapeutics SA, as Director.
Aktiva positioner av Caroline Thielen
| Företag | Position | Start |
|---|---|---|
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Direktör/Styrelseledamot | - |
Promethera Therapeutics SA
 Promethera Therapeutics SA Pharmaceuticals: OtherHealth Technology Provides cell therapies for treatment of liver diseases | Direktör/Styrelseledamot | - |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Direktör/Styrelseledamot | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
19
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Exevir Bio BV
Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Health Technology |
Promethera Therapeutics SA
Promethera Therapeutics SA Pharmaceuticals: OtherHealth Technology Provides cell therapies for treatment of liver diseases | Health Technology |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Health Technology |
